TG THERAPEUTICS, INC. - COMMON STOCK (TGTX)

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COMMON STOCK
Shares outstanding
158,835,667
Number of holders
84
Total 13F shares, excl. options
27,922,586
Shares change
-1,509,785
Total reported value, excl. options
$169,210,192
Value change
-$14,367,082
Number of buys
42
Number of sells
30
Price
$6.06

Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2016

As of 30 Jun 2016 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 27,922,586 shares of stock of the company.
Largest 10 holders included BRIDGER MANAGEMENT, LLC, FMR LLC, RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, UBS ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, and COLUMBUS CIRCLE INVESTORS.
This table shows 84 institutional shareholders of the security as of 30 Jun 2016.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.